-%* %&/ +0 &**0*8%#* %+&.):
$##%#0* *
)*%++ &%,+# %
#+ *"****$%+ &%'+,#)$.&)" $) %) *"****$%+') $
&.)& %$ # *"****$%+ $ #+&/ +0')&3# % +)(,# +0$&% +&) % )')+ ,#++&/ +0 %&+&/ +0 ,+% +0 &**0
,+,))%* % *"****$%+
3% + &%+ *"# #) *!#-(!0' 7 /./*#0()# '/#*-/* *'*"$'.4./ (.
- .0'/$)"!-*( 3+*.0- /*) )1$-*)( )/'#5-?
*0)/1 - ./
) + &%# *"****$%+)&**
% .'%#$+ '%$#$)"'%)) %$$-
1)%+ 3+ &%#/# '/#+-*' (.- 0. 4/#
# ($'B
&*:*'&%*****$%+
#/- /# # '/#*0/*( ./$7 - )/
3+*.0- ' 1 '.B
/'&*,)****$%+
*2(0#*!/# # ($'- + *+' 3+*. /*0-$)"+ -$**!/$( B*2()4+ *+' -
3+*. B
*")+) 1+ &%#/$./# 3/--$.&*!# '/#+-*' (.$)/# 3+*. +*+0'/$*)B
&$'&%%+*&+A@ * &%
# ($'#-/ -$5/$*)
*3$$/4 ./$)"*3$$/4/#24. -" / ./$)"
*. @ .+*). )3/-+*'/$*)* '$)"
% .'%#%, )-() $ $)76()$)*'-0 ( %$$)')-
) $ + % *"****$%++'* ) + &%#'')& A@;A@
Hazard identification
In vivo animal experiments Endpoint assays (mortality) Epidemiological studies Environmental monitoring
Chemical characterization Toxicity pathway identification Some targeted animal testing Population context
Dose-response assessment
Extrapolation of in vivo animal results to humans
Modeling based on a battery of in vitro assays, systems biology and reverse toxicokinetics
Exposure assessment
Receptors Pathways of exposure Concentration, duration Internal dose
Population data Exposure data (biomonitoring and personal exposure monitoring)
Risk characterization
Quantitative risk assessment models
Biologically relevant health risk assessment
Emerging Technologies
+&*&)##*%#0* * '+ # '0*- . )
/ %>%*+),$%++ &%
%( $($1
) % '#&/ %>
cell 0 cell 0
&% +&) %##) )+ &%&%+/ %>%*+),$%+
$11)"1/#1(1%, %"1/%"16=/755: $$$$
11 ))))))) """""""""1/ ####1
##,#)*'&%**++0+/ %>%*+),$%+
')%)"1/$-"%& %$"-) "# ()'-/7568 ') % ) """" $- """"%&)
$ #&/ +0)&3# %
&/ +0)&3# %)&!+&%'+,#)$.&)"
-6.38
-3.160.05
3.266.48
9.69
EC RATE
8.37
5.70
3.03
0.35
-2.32-4.99
EC Adoptation
-4.40
-3.05
-1.71
-0.36
0.99
2.34
EC Efficiency
PLOT OF EC EFFICIENCY BY EC ADOPTATION BY EC RATE
cluster: CLUSTER ONE CLUSTER TWO
CLUSTER THREE CLUSTER FOUR
CLUSTER FIVE CLUSTER SIX
CLUSTER SEVEN
Mean Graph For CytochalasinB
-2.0 -1.5 -1.0 -0.5 0.0 0.5 1.0 1.5
A549
ARPE
BEAS
HEPG
SKNS
VSMC
Hazard Identification Toxicity Profiling
Cytochalasin B - VSMC
Log10 concentration (uM)
-4 -3 -2 -1 0 1 2
T
o
x
i
c
E
f
f
e
c
t
-150
-100
-50
0
50
100
15024 hr48 hr72 hr96 hr
HTS Cell Panel
Cell Population Kinetics
Dose-Response
Mean Graph
Cluster Analysis Mode of Action
GHS Classification
Reverse Toxicokinetics
In Vivo LD50
Exposure Standards; Health Risk Assessment
Population Exposure
Risk Characterization
Bioinformatics
Chemical Characterization
Chemicals
Metabolites
In Vitro Dose
Mutagenicity Assay
Specialized Assays
LD50 (mmol/kg) vs KC50 (mM)_geomean in 6 Human Cell Lines
log KC50 (mM)_geomean
-10 -8 -6 -4 -2 0 2 4 6
l
o
g
L
D
5
0
R
a
t
(
m
m
o
l
/
k
g
)
-6
-4
-2
0
2
4
logLD50 (mmol/kg) = 0.560xlogKC50 + 0.155
regression line (r = 0.86, r2 = 0.74)RC(12) Prediction Line (r =0.87, r2 = 0.77)Log-5 (RC12) Log +5 (RC12) RC(282) Prediction line (r = 0.67, r2 = 0.45)
&/ +0)&3# %)&!+!+ -*
*0- *!# ($'.-).+*-/)!/
/#24*! 3+*.0- *' 0'-$)$/$/$)" 1 )/
0@ ''0'-*-") '' - .+*). . ''0'- 7 /.$..0 ' .$*).
-")H.4./ (I+/#*'*"4
)$1$0'*-")$.($. .
*+0'/$*) 7 /.*.4./ ( 7 /.
#)$.(*!/$*)
* *!/$*)*3$$/4+/#24
1 -. *0/*( +/#24*0- /**0/*( +/#24
0
.
@
7
/
+
/
#
2
4
#)$.(
*3$
1 *01. Human exposure standards 2. Prediction of in vivo starting doses 3. GHS Classification of chemicals
&/ +0)&3# %)&!+/') $%+#* %
)1$-*)( )/'*)/($))/. ! - ) *(+*0).HI ! - ) # ($'.HI
-$*-$/4# ($'. /#24/$1/*-.@)#$$/*-. +- . )//$1 .*!'..@
3+ -$( )/'# ($'.KUOO
'') 'FT ''$) .
$( @ .+*). 0-1 . *. @ .+*). 0-1 .TO
&/ +0)&3# %)&!+##%#
Cell Line(* Origin Cell Type +Q $1 - +/* ''0'--$)*(@PW 4 *-('- /$)' ''H+$"( )/ ITSW 0)" )*-$)*(H'1 *'-.' ''I@@ -$) 0-*'./*(Q 0)" *-('-*)#$' ''..VS)/ *-('.(''$)/ ./$) $) 4 )' '' )*-$)*(E@ *-/ *-('.(**/#(0.' H*-/IRR *0. (-4* $-*'./
JI0-- )/ '''$) .> +Q
+%#0* *
$?: %)') %+ %
+&&0
$?: %)') %+ %#,*+) %
-6.38
-3.160.05
3.266.48
9.69
EC RATE
8.37
5.70
3.03
0.35
-2.32-4.99
EC Adoptation
-4.40
-3.05
-1.71
-0.36
0.99
2.34
EC Efficiency
PLOT OF EC EFFICIENCY BY EC ADOPTATION BY EC RATE
cluster: CLUSTER ONE CLUSTER TWO
CLUSTER THREE CLUSTER FOUR
CLUSTER FIVE CLUSTER SIX
CLUSTER SEVEN
-6.38
-3.160.05
3.266.48
9.69
EC RATE
8.37
5.70
3.03
0.35
-2.32-4.99
EC Adoptation
-4.40
-3.05
-1.71
-0.36
0.99
2.34
EC Efficiency
PLOT OF EC EFFICIENCY BY EC ADOPTATION BY EC RATE
cluster: CLUSTER ONE CLUSTER TWO
CLUSTER THREE CLUSTER FOUR
CLUSTER FIVE CLUSTER SIX
CLUSTER SEVEN
'*/*!-*2/#9$ )44")4/
%)'+&Mean Graph For CytochalasinB
-2.0 -1.5 -1.0 -0.5 0.0 0.5 1.0 1.5
A549
ARPE
BEAS
HEPG
SKNS
VSMC
Mean Graph For CytochalasinD
-0.8 -0.6 -0.4 -0.2 0.0 0.2 0.4 0.6
A549
ARPE
BEAS
HEPG
SKNS
VSMC
Mean Graph For LatrunculinB
-2.0 -1.5 -1.0 -0.5 0.0 0.5 1.0 1.5
A549
ARPE
BEAS
HEPG
SKNS
VSMC
Mean Graph For LatrunculinA
-2.5 -2.0 -1.5 -1.0 -0.5 0.0 0.5 1.0 1.5
A549
ARPE
BEAS
HEPG
SKNS
VSMC
MeMeMeMeMeMeanananananan GGGGGGrarararararaphphphphphphp FFFFFForororororor CytochalasinB
-2.0 -1.5 -1.0 -0.5 0.0 0.5 1.0 1.5
A549
AAARPE
BBEAS
HHHHEPG
SSKNS
VVVVSMC
MeMeMeMeMeMeanananananan GGGGGGrarararararaphphphphphphp FFFFFForororororor CytochalasinD
-0.8 -0.6 -0.4 -0.2 0.0 0.2 0.4 0.6
A549
ARPE
BEAS
HEPG
SKNS
VSMC
Mean Graph For LatrunculinB
-2.0 -1.5 -1.0 -0.5 0.0 0.5 1.0 1.5
A549
ARPE
BEAS
HEPG
SKNS
VSMC
Mean Graph For LatrunculinA
-2.5 -2.0 -1.5 -1.0 -0.5 0.0 0.5 1.0 1.5
A549
AARPE
BBEAS
HHEPG
SSKNS
VVVVSMC
) + &%&+&) *
9 C$;".
9 CC?$;".
9 C?B??$;".
9 B??A7???$;".9 A???C7???$;".
) + &%&+&) * Slope Inter-
cept RC-IC NRU RTCA
Dose Finding
RTCA Definitive
RTCA Definitive
Measure IC50 IC50 KC50 KC50 KC50 Cell Line M
HNK 9 Human
Geomean ACHN HepG2
Chemical 347 51 12 12 12
RC (374) 0.435 0.625 40% 29% 50% 42% 36%
Over-predicted 34% 40% 50% 50% 46%
Under-predicted 26% 31% 0% 8% 9%
Correlation with LD50 values ( r )
0.67
0.68 0.64 0.91(*
0.84 0.69
JIACHN r = 0.91, HepG2 r = 0.64
) + &%&C?LD50 (mmol/kg) vs KC50 (mM)_geomean in 6 Human Cell Lines
log KC50 (mM)_geomean
-10 -8 -6 -4 -2 0 2 4 6
l
o
g
L
D
5
0
R
a
t
(
m
m
o
l
/
k
g
)
-6
-4
-2
0
2
4
logLD50 (mmol/kg) = 0.560xlogKC50 + 0.155
regression line (r = 0.86, r2 = 0.74)RC(12) Prediction Line (r =0.87, r2 = 0.77)Log-5 (RC12) Log +5 (RC12) RC(282) Prediction line (r = 0.67, r2 = 0.45)
L
D
5
0
LDLDLDLDLDLD50 ((((((mmmmmmmm llolololol/k/k/k/k/k/k ))g)g)g)g) vvvvssss KCKCKCKCKCKC50 (((((( MMmMmMmMmM))))))_gegegegeomomomomeaeaeaeannnn iiinininin 666666 HHHHHHumumumumanananan CCCCCC llelelelelllllll LiLiLiLiLiLinenenenessss
log KC50 (mM)_geomean
-10 -8 -6 -4 -2 0 2 4 6
l l
o
l
o
g g
L L L
m
m
m
m
l
o
l
o
l
/
k
/
k
/
k
)
g
)
g
)
-6
-4
-2
0
2
4
logLD50 (mmol/kg) = 0.560xlogKC50 + 0.155
regression line (r = 0.86, r2 = 0.74)RC(12) Prediction Line (r =0.87, r2 = 0.77)Log-5 (RC12) Log +5 (RC12)RC(282) Prediction line (r = 0.67, r2 = 0.45)
L
D
5
0
* % & #*'&%**+&) +#+ *"*
Gene mutation Reporter gene
Gene expression Biomarkers
Molecular initiating
event
Cellular effects
Organelle responses
Receptor binding Ligands
Protein adducts DNA adducts
Ligand binding Enzyme activity Co-activators
Chemical x-actions
Gene activation Protein production
Signaling
Injury Stress
Apoptosis Autophagy Necrosis
Transformation
Cytotoxicity Flow cytometry
Imaging
Biochemical assays s Molecular assays s Cellular assays
)
'
*
!
.
.
4
.
Point of departure
concentration in vitro
Acceptable concentration
in vitro (g/l)
1
-
.
7
/
.
In vivo human exposure standard
(mg/kg/day)
Point of
Systems biology
Reverse toxicokinetics
Toxicity pathway
+),# +0%,$%#+
%)* %',# .)%**%&%)%&,+.+)*,''# *&),$%&%*,$'+ &%
$'+*&%+)&'&% + - + *< %,*+)07) ,#+,)=&%$ )& #%$ #.+)(,# +0
,#+&)0%* /$*)'+ -!*-() ./)-. (+'$)")/ ./$)"- ,0$- ( )/. $-*$'H?*'$
#** 3+ &%&&)*
Standard Water Toxicity Bioassays
) &3*) #,$ %*% % + &%< )&+&/= $%&'#,*'#+0,),*$&)+# +0 '% $% $$& # 1+ &%%)')&,+ &%
(5*)@$* "-*
-#&'$%+&:*+)&/ +0 &**0 Develop and demonstrate the utility of a human cell-
based / %> screening assay to assess toxicity of various source waters
Introduce a toxicity index to evaluate degrees of toxicity in various types of water *$/11/)"1/$'&*" ) %$TCRC Curve
Dose-response
Curve Toxicity Heat
Map Water Toxicity
Index Bar
S1 S2 S3 S4 S5 S6 S7 S8 S9 S10 S11 S120
1
2
3
4
5
6
7
8
Water SamplesT
o
x
i
c
i
t
y
I
n
d
e
x
Concentration
W
a
t
e
r
S
a
m
p
l
e
s
Colormap for Toxicity Index in HepG2
80% 60% 40% 30% 20% 10%
S1
S2
S3
S4
S5
S6
S7
S8
S9
S10
S11
S12
1
2
3
4
5
6
7
8
9
Sorry,thedatawillbesharedonceitispublished.
Sorry, the data will be shared once it is published.Sorry,thedatawillbesharedonceitispublished.
Sorry,thedatawillbesharedonceitispublished.
Sorry,thedatawillbesharedonceitispublished.
Sorry the data will be shared once it is publishedSorry,thedatawillbesharedonceitispublished.
Sorry,thedatawillbesharedonceitispublished.
Speed (High-throughput screening) Early indication of hazard Human relevance Multiple cell types (Cell panel) Exposure relevance Mixtures Quick evaluation of environmental incidents Cost-effective
%3+*&++/ %> &**0
+)+)&%+$ %%+*&)"
)&++ %,)+)) +
).&
)#,+ &%%#+ *"* ))$%0 2)%++0'*& )'#,+%+*)&$
. )%&*&,)* $&*+ $'&)+%+++)+**%')+ #*
++-%&,%+&&%+) ,++&) &-*,#)%)*' )+&)0 **
/#()0
,)+1)+ #%,##,#)'&%**
*$ )"1/$"-()/755=/688/;982;9=
C?#,*&&,)0'*&)+ ,#+* %::@##*
*$ )"1/$"-()/755=/688/;982;9=
Urban dustDiesel exhaust
&1)&,*A9C%%&')+ #*
&/ +0)&3#%C?&)+ ,#+* %::@##*
')%)"1/$-"%& %$"-) "# ()'-/7568 '''' )))))))) %%%% )))))))) """""""""1/ $$$$----"""""""%"%"%"%&&&))))))))
Quartz particles (Q66)Urban dust (SRM1649a)
Concentrated air particles (CAPs)
%&+&/ +0 )&. %+)) %+,$%#+
%*+0) *"*&%%&$+) #* %&$+) #*-,% (,+&/ ')&')+ *
,*&+ )'0* #')&')+ *
&/ +0)&3##*)+. +%%% A
')%)"1/$"-) # )/7568/=84>5
&/ +0)&3#&:@##*)+. +%)+ #*
')%)"1/$-"%& %$"-) "# ()'-/7568
,+% +0 &**0
,++ &%*)%* %+*(,%&%,#&+ *. + %##,*0$,+%*
+)+0&),+% +0*+ % &%* )+ &%* $ #*+),+,)%#**7')&')+ * + *$7)+ - +07 & #+ - +0 &,+*&/'&*,)7 &- # # +07+)++ **,
$+&* +) #+*+*&)%$,++ &%*
)&&&&%'+,++ &% &**0
''"-*2/#&$) /$. . '$) )/#- .#*' ..4'$-/$*)
+-*0$$'$/4 *(+-$.*)*!$*..4. $11/)"1$" %$"#/7567/651655
&%#,* &%*,++ &%**0 -$&%*+)++')&&&&%'+&%&-#
&**0&)+++ &%&$,++##* *$+&')&- *'&.),#+&. + )
+)&,',+&)%&+&/ +0+*+ % -,*7&)+3)*++ $7##)&.+" %+ ,)-*
&)+(,%+ 3+ &%&$,+%+##* )*,#+*&+ %. ++) %#&*)$%+
. ++&*&+&%-%+ &%#%&+&/ +0**0 ,)+)'++ &%%-# + &%&+**0 *)(, )
&)*)% %+,#$,+% %- )&%$%+#$ #*
,+,))%* %&/ +0*+ %% *"****$%+
%+ 3+ &%&+&/ +0'+.0*%$&&+ &%&$ #*
%+)')++ &%%-#,+ &%&+ & # %&)$+ &%)&$#+) *"****$%+')*'+ -
-#&'$%+&$% *+ ##0:*') + -$*& & #)*'&%*
$)%&%.)*&''# + &% %',# #+) *"****$%+
,+,))%* %%&0
&%+ %, $')&-$%+& :+)&,',+*)% %+%& *
-#&'$%+&+&/ +0:*3#$&% +&) % %*+),$%+*:*%* + -7'&)+#7*+#- *:&) )(,# +0%.+)+&/ +0****$%+
,#+ '#/ %& $'%))0*. +&+)##:*+%& *
"%&.#$%+*
#&)+&)*8
'&%*&)*8
#)&4*0A
0 ./$*).B
Top Related